Fluvastatin Enhances the Inhibitory Effects of a Selective AT1 Receptor Blocker, Valsartan, on Atherosclerosis
Hypertension - United States
doi 10.1161/01.hyp.0000145179.44166.0f
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2004
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)